Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
During Q3 2025, the Bristol Gate US Equity Strategy lagged the S&P 500 benchmark (-0.6% net return vs 8.1% for S&P 500 TR) due to defensive positioning and a lack of exposure to AI-dominated mega-cap tech stocks and value-based sectors. However, the portfolio...
— Achilleas Taxildaris
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on UnitedHealth Group Incorporated
UnitedHealth has been a major laggard for the past quarter and year. However, since CEO...
UnitedHealth faced heightened headlines and legal controversy following the assassination of its insurance CEO, alongside ongoing political scrutiny over claims management. Management remains committed...
At the beginning of the quarter, we significantly added to UnitedHealth, approximately doubling the size of the position.